<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-27T05:24:29Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/18333" metadataPrefix="rdf">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/18333</identifier><datestamp>2026-02-03T12:25:11Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37959</setSpec></header><metadata><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:riuma.uma.es:10630/18333">
      <dc:title>Effects of galanin n-terminal fragment (1-15) in sac- charin self-administration and sucrose preference test in rats.</dc:title>
      <dc:creator>García-Durán, Laura</dc:creator>
      <dc:creator>Cantero-García, Noelia</dc:creator>
      <dc:creator>Flores-Burgess, Antonio</dc:creator>
      <dc:creator>Gago-Calderón, Belén</dc:creator>
      <dc:creator>Allén, Francisco</dc:creator>
      <dc:creator>Orio, Laura</dc:creator>
      <dc:creator>Narváez-Bueno, José Ángel</dc:creator>
      <dc:creator>Fuxe, Kjell</dc:creator>
      <dc:creator>Santín-Núñez, Luis Javier</dc:creator>
      <dc:creator>Díaz-Cabiale,  Zaida</dc:creator>
      <dc:creator>Millón-Peñuela, Carmelo</dc:creator>
      <dc:subject>Depresión mental</dc:subject>
      <dc:subject>Serotonina</dc:subject>
      <dc:description>The Galanin N-terminal fragment (1-15) [GAL(1-15)] induces depressant- and anxiogenic- like actions in several behavioral tests, and these effects were significantly stronger than the ones induced by Galanin (1-29). Since, anhedonia is a core feature of major depressive disor- der, we have analyzed GAL(1-15) actions in two anhedonic-like behaviour tests: saccharin Self-administration and Sucrose Preference test.&#xd;
Three sets of experimemts were conducted in the saccharin Self-administration test. In the first, a dose-response curve of GAL(1-15) 1nmol, 3nmol or vehicle was performed. We have also compared the effects in the number of saccharine reinforcements of Galanin (1-29) 3nmol and GAL(1-15) 3nmol. In the last experiments, rats received i.c.v. GAL(1-15) 3nmol and the GALR2 antagonist M871 3nmol.&#xd;
In Sucrose Preference test, we have analyzed the effects of GAL(1-15) 3nmol in the sucrose intake and preference after 2, 8 and 24 h.&#xd;
GAL(1-15) 3nmol significantly decreased the number of reinforcement of saccharin self- administer (p&lt;0.01), while 1nmol lacked effect. GAL(1-15) also significantly reduced the number of reinforcement (p&lt;0.01) compared with Galanin (1-29). The GALR2 antagonist M871 significantly blocked (p&lt;0.05) the decrease in the number of saccharin reinforcements administration induced by GAL(1-15).&#xd;
In the Sucrose Preference test, GAL(1-15) decreased the sucrose intake 8 (p&lt;0.05) and 24 hours (p&lt;0.01) after administration.&#xd;
In the current study, we described for the first time that GAL(1-15) induced a strong anhe- donia-like phenotype in the saccharin self-administration and Sucrose Preference test, con- firming an important role of this neuropeptide in anhedonia, a core feature of major depres- sive disorders.</dc:description>
      <dc:date>2019-09-12T11:48:18Z</dc:date>
      <dc:date>2019-09-12T11:48:18Z</dc:date>
      <dc:date>2019</dc:date>
      <dc:date>2019-09-12</dc:date>
      <dc:type>conference output</dc:type>
      <dc:identifier>https://hdl.handle.net/10630/18333</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
   </ow:Publication>
</rdf:RDF>
</metadata></record></GetRecord></OAI-PMH>